alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS



         As   independent   public   accountants,   we  hereby  consent  to  the
incorporation  of our report included in this Form 10-KSB/A-4 into the Company's
previously filed  Registration  Statements,  File Numbers  33-47479,  33-879650,
33-96436,  33-97760,  33-99792,  33-99794,  333-000140,   333-001070,  333-3424,
333-5781,  333-7097,  333-10681,  333-18003,  333-21095,  333-22725,  333-87908,
33-97710, 333-18347, 333-25209 and 333-28251.



                                                        /s/  ARTHUR ANDERSEN LLP

Boston, Massachusetts
July 7, 1997
EXHIBIT
32.1 and 32.2


CERTIFICATION
PURSUANT TO RULE 13a-14(b) OF THE SECURITIES EXCHANGE ACT OF 1934,AS
AMENDED,
 AND
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002
 
   The
undersigned officer of Consorteum Holdings, Inc. (formerly known as Implex
Corporation and hereinafter the "Company") hereby certifies to such officer's
knowledge that the Company's Annual Report on Form 10-K for the year ended
December 31, 2008 (the "Report"), as filed with the Securities and Exchange
Commission on the date hereof, fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the
information contained in the Annual Report fairly presents, in all material
respects, the financial condition and results of operations of the Company. This
certification is provided solely pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be
deemed to be part of the Report or "filed" for any purpose
whatsoever.





Date:
      April 13, 2009
                
                /s/ Richard C. FoxName:
                Richard
      C. FoxTitle:
                Chief
      Executive Officer andChief Financial
Officer
**Exhibit 31.01**

**CERTIFICATIONPURSUANT TO 15 U.S.C. SECTION 7241,AS ADOPTED PURSUANT TOSECTION 302 OF THESARBANES-OXLEY ACT OF 2002**

I, **TOM THIMOT**, certify that:

1.     I havereviewed this Form 10-Q of GoRemote Communications, Inc.;

2.     Based onmy knowledge, this report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statementsmade, in light of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

3.     Based onmy knowledge, the financial statements, and other financial informationincluded in this report,fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periodspresented in this report;

4.     Theregistrant’s other certifying officer(s) and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined inExchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and wehave:

a)                Designed suchdisclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this report is being prepared;

b)               Evaluated theeffectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

c)                Disclosed in thisreport any change in the registrant’s internal control over financial reportingthat occurred during the registrant’s most recent fiscal quarter that hasmaterially affected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting; and

5.     Theregistrant’s other certifying officer(s) and I have disclosed, based onour most recent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of the registrant’s board ofdirectors (or persons performing the equivalent functions):

a)                All significantdeficiencies and material weaknesses in the design or operation of internalcontrol overfinancial reporting which are reasonably likely to adversely affect theregistrant’s ability to record, process, summarize and report financialinformation; and

b)               Anyfraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financialreporting.
| Date: March 14, 2005 | By:    | /s/ TOM  THIMOT                              |
|---------------------------|--------|----------------------------------------------|
|                      |   | Tom Thimot                                   |
|                      |   | President & Chief Executive Officer |

 

----
[Federal Register Volume 60, Number 34 (Tuesday, February 21, 1995)]
[Notices]
[Pages 9677-9678]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-4104]




-----------------------------------------------------------------------


DEPARTMENT OF ENERGY
[EL95-28-000]

New York State Electric & Gas Corporation; Notice of Filing
February 14, 1995.
    Take notice that on February 14, 1995, New York State Electric & 
Gas Corporation (NYSEG), filed a Petition, for Declaratory Order, 
Complaint, and Request for Modification of Rates in Power Purchase 
Agreements Imposed Pursuant to the Public Utility Regulatory Policies 
Act of 1978 (Petition). The Petition requests that this Commission: (1) 
issue a declaratory order providing that the Public Utility Regulatory 
Policies Act of 1978 (PURPA) prohibits NYSEG from being required to pay 
rates in excess of its avoided cost for energy purchased from Lockport 
Energy Associates, L.P. (Lockport) and Saranac Power Partners, L.P. 
(Saranac) under power purchase agreements mandated pursuant to PURPA; 
(2) promptly take action to modify the rates under the Lockport and 
Saranac agreements to insure compliance with PURPA's avoided cost rate 
ceiling; or (3) refer this matter to the New York Public Service 
Commission (NYPSC) with a declaration that the Commission invests the 
NYPSC with the authority and obligation to modify the agreements to 
conform them to PURPA's rate standard.
    NYSEG asserts that its agreements with Lockport and Saranac require 
NYSEG to purchase energy at rates in excess of its avoided cost, in 
violation of PURPA's avoided cost rate standard, that such rates have 
never been acceptable to NYSEG, and that NYSEG entered into its 
agreements with Lockport and Saranac only after being ordered to do so 
by the NYPSC.
    Any person desiring to be heard or to protest said filing should 
file a motion to intervene or protest with the Federal Energy 
Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 
20426, in accordance with Rules 211 and 214 of the Commission's Rules 
of Practice and Procedure (18 CFR 385.211 and 18 CFR 385.214). All such 
motions or protests should be filed on or before March 7, 1995. 
Protests will be considered by the Commission in determining the 
appropriate action to be taken, but will not serve to make 
[[Page 9678]] protestants parties to the proceeding. Any person wishing 
to become a party must file a motion to intervene. Copies of this 
filing are on file with the Commission and are available for public 
inspection.
Lois D. Cashell,
Secretary.
[FR Doc. 95-4104 Filed 2-17-95; 8:45 am]
BILLING CODE 6717-01-M
Exhibit 23.3




INDEPENDENT AUDITOR'S CONSENT




To the Board of Directors of
Tremont Advisers, Inc.


We  hereby  consent  to the  incorporation  by  reference  in  the  Registration
Statement on Form S-8 (No.  33-78346)  pertaining to the Tremont Advisers,  Inc.
Savings Plan of our report dated  February 18, 2000 on the financial  statements
of American  Masters  Broad Market Prime Fund,  L.P. as of December 31, 1999 and
for the year then ended which  report is  included in the Annual  Report on Form
10-KSB of Tremont Advisers, Inc. for the year ended December 31, 2000.




GOLDSTEIN GOLUB KESSLER LLP
New York, New York

March 7, 2001








                                       91
#### WESTERN NORTH CAROLINA CONFERENCE and H. V. COX, B. J. EARPE, GEORGE T. GUNTER, CYRUS SHOFFNER and EARL FARRELL, Officers of the Said Conference; G. O. LANFORD, T. J. GREEN, M. A. POLLARD, H. V. COX, CYRUS SHOFFNER, GEORGE T. GUNTER and W. H. FREEMAN, the Executive Committee of the Said Conference, and MR. AND MRS. J. Q. PUGH, MRS. H. B. KINNEY, MRS. HELEN K. RICH, FRANK WILSON, MURIEL PUGH COX, FRANCES PUGH SMITH, VIRGINIA PUGH and MRS. RUTH WILSON DAVIS, MR. AND MRS. J. W. WILSON, MRS. ODELL WRIGHT, SARAH ELLISON, FANNIE ELLISON, RUTH CHEEK KIVETT, D. G. CRAVEN, BEULAH DAVIS, RALPH WILSON, TIFFANY WILSON, MRS. ETTA HENDRICKS, BESSIE L. STOUT, TABITHE KELLING, LOLA PUGH CADDIS, JOHN PUGH, JR., ANNIE E. CRAVEN, WILLIAM CHEEK, MACIE CHEEK, CARRIE PUGH, JOE PUGH, NORDIE ALLRED HOLDER, G. H. KINNEY, MAXINE CRAVEN LEWIS, on Behalf of Themselves and All Other Members of PLEASANT CROSS CHRISTIAN CHURCH, v. GEORGE TALLEY, J. H. MALONE, TED TROGDON, A. M. BURNS, ED WRIGHT, MILDRED MALONE and CLARENCE MALONE, and All Such Other Persons Whose Names and Addresses Are Unknown, Who Are Affiliated With and Claim to Be Members of an Organization Known and Designated as the INDEPENDENT CHRISTIAN CHURCH, a Movement Fostered and Organized Since 14 November, 1943, by the Said GEORGE M. TALLEY.

(Filed 30 October, 1946.)

Pleadings § 16: Appeal and Error § 40b—

Where a demurrer for misjoinder of parties is not interposed until after answer is filed it is too late to be considered as a matter of right but is *655addressed to the sound discretion of the court, and its adverse ruling thereon is not subject to review.

Appeal by defendants from *Clement, J.,*at July Term, 1946, of RaNdolph. Affirmed.

After answering, tbe defendants moved to dismiss tbe action as to tbe plaintiff Conference for tbat it is not a proper party plaintiff. Tbe motion was denied and defendant appealed.

*H. M. Robins and Long & Long for plaintiffs, appellees.*

*Walter Siler, J. G. Prevette, and Seawell & Seawell for defendants, appellants.*

Per Curiam.

Defendants’ motion is in effect a demurrer for misjoinder of parties, interposed after answer was filed. It came too late. *Goldsboro v. Supply Co.,*200 N. C., 405, 157 S. E., 58; *Schnibben v. Ballard & Ballard Co.,*210 N. C., 193, 185 S. E., 646; *Ezzell v. Merritt,*224 N. C., 602, 31 S. E. (2d), 751; McIntosh, N. C. P. & P., 457. Having answered, bis motion was addressed to tbe sound discretion of tbe court. Its adverse ruling is not subject to review.

The judgment below is

Affirmed.
**Exhibit 12.1**

**CERTIFICATION**

I, GregoryA.C. Yull, certify that: 

1.    I have reviewed this annual report on Form 20-F of IntertapePolymer Group Inc.; 

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit tostate a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in allmaterial respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this annual report; 

4.    The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls andprocedures [as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)] and internal control over financial reporting [as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)] for the Company and have: 

a.    Designed such disclosure controls and procedures, or caused such disclosure controls and proceduresto be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report isbeing prepared; 

b.    Designed such internal control over financing reporting, or caused such internalcontrol over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generallyaccepted accounting principles; 

c.    Evaluated the effectiveness of the Company’s disclosurecontrols and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this annual report based on such evaluation; and 

d.    Disclosed in this report any change in the Company’s internal control over financial reportingthat occurred during the period covered by this annual report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and 

5.    The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control overfinancial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions): 

a.    All significant deficiencies and material weaknesses in the design or operation of internal controlover financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and 

b.    Any fraud, whether or not material, that involves management or other employees who have asignificant role in the Company’s internal control over financial reporting. 

Date: March 29, 2017
II 

117TH CONGRESS 

2D SESSION S. 3478 

To provide for the designation of biological products as qualified infectious 

disease products. 

IN THE SENATE OF THE UNITED STATES 

JANUARY 11 (legislative day, JANUARY 10), 2022 

Mr. CASEY (for himself, Mr. CASSIDY, and Mr. MURPHY) introduced the following bill; which was read twice and referred to the Committee on 

Health, Education, Labor, and Pensions 

A BILL 

To provide for the designation of biological products as 

qualified infectious disease products. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Generating Antibiotic 

5 Incentives Now Through Opening Opportunities to Lever6 age Science Act of 2022’’ or the ‘‘GAIN TOOLS Act of 

7 2022’’. 


pbinns on DSKJLVW7X2PROD with BILLS
2 

•S 3478 IS

1 SEC. 2. EXPANDING QUALIFIED INFECTIOUS DISEASE 

2 PRODUCTS TO INCLUDE BIOLOGICAL PROD3 UCTS. 

4 (a) IN GENERAL.—Section 505E of the Federal 

5 Food, Drug, and Cosmetic Act (21 U.S.C. 355f) is amend6 ed— 

7 (1) in subsection (c)— 

8 (A) in paragraph (2), by striking ‘‘; or’’ 

9 and inserting ‘‘;’’; 

10 (B) in paragraph (3), by striking the pe11 riod and inserting ‘‘; or’’; and 

12 (C) by adding at the end the following: 

13 ‘‘(4) an application pursuant to section 351(a) 

14 of the Public Health Service Act.’’; 

15 (2) in subsection (d)(1), by inserting ‘‘of this 

16 Act or section 351(a) of the Public Health Service 

17 Act’’ after ‘‘section 505(b)’’; and 

18 (3) by amending subsection (g) to read as fol19 lows: 

20 ‘‘(g) QUALIFIED INFECTIOUS DISEASE PRODUCT.— 

21 The term ‘qualified infectious disease product’ means a 

22 drug or biological product for human use that— 

23 ‘‘(1) is— 

24 ‘‘(A) an antibacterial or antifungal drug; 

25 or 


pbinns on DSKJLVW7X2PROD with BILLS
3 

•S 3478 IS

1 ‘‘(B) a biological product that acts directly 

2 on bacteria or fungi or on substances produced 

3 by such bacteria or fungi; and 

4 ‘‘(2) is intended to treat a serious or life-threat5 ening infection, including such an infection caused 

6 by— 

7 ‘‘(A) an antibacterial or antifungal resist8 ant pathogen, including novel or emerging in9 fectious pathogens; or 

10 ‘‘(B) qualifying pathogens listed by the 

11 Secretary under subsection (f).’’. 

12 (b) PRIORITY REVIEW.—Section 524A(a) of the Fed13 eral Food, Drug, and Cosmetic Act (21 U.S.C. 360n–1(a)) 

14 is amended by inserting ‘‘of this Act, or section 351(a) 

15 of the Public Health Service Act, that requires clinical 

16 data (other than bioavailability studies) to demonstrate 

17 safety or effectiveness’’ before the period. 

Æ 


pbinns on DSKJLVW7X2PROD with BILLS
II 

117TH CONGRESS 

2D SESSION S. 3781 

To amend the Food and Nutrition Act of 2008 to exclude a basic allowance 

for housing from income for purposes of eligibility for the supplemental 

nutrition assistance program. 

IN THE SENATE OF THE UNITED STATES 

MARCH 8 (legislative day, MARCH 7), 2022 

Ms. DUCKWORTH (for herself, Ms. MURKOWSKI, Ms. KLOBUCHAR, Mrs. 

GILLIBRAND, Mr. DURBIN, Mr. BOOKER, Mrs. FEINSTEIN, Ms. ROSEN, 

Ms. WARREN, Mr. BLUMENTHAL, Mrs. MURRAY, Mr. PADILLA, Mr. 

WARNOCK, and Ms. BALDWIN) introduced the following bill; which was 

read twice and referred to the Committee on Agriculture, Nutrition, and 

Forestry 

A BILL 

To amend the Food and Nutrition Act of 2008 to exclude 

a basic allowance for housing from income for purposes 

of eligibility for the supplemental nutrition assistance 

program. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. EXCLUSION OF BASIC ALLOWANCE FOR HOUS4 ING FROM INCOME. 

5 Section 5(d) of the Food and Nutrition Act of 2008 

6 (7 U.S.C. 2014(d)) is amended— 


pbinns on DSKJLVW7X2PROD with BILLS
2 

•S 3781 IS

1 (1) in paragraph (18), by striking ‘‘and’’ at the 

2 end; 

3 (2) in paragraph (19)(B), by striking the period 

4 at the end and inserting ‘‘; and’’; and 

5 (3) by adding at the end the following: 

6 ‘‘(20) a basic allowance for housing paid to a 

7 member of a uniformed service under section 403 of 

8 title 37, United States Code.’’. 

Æ 


pbinns on DSKJLVW7X2PROD with BILLS
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE ANNUAL
REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE ANNUAL PERIOD ENDED DECEMBER 31, 1997.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                       4,480,112
<SECURITIES>                                         0
<RECEIVABLES>                                  749,603
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0<F1>
<PP&E>                                      34,234,667
<DEPRECIATION>                              12,630,987
<TOTAL-ASSETS>                              47,348,906
<CURRENT-LIABILITIES>                                0<F1>
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                  27,665,652
<TOTAL-LIABILITY-AND-EQUITY>                47,348,906
<SALES>                                              0
<TOTAL-REVENUES>                             6,606,199
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             4,111,631
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           1,557,497
<INCOME-PRETAX>                              1,479,260
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          1,479,260
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,479,260
<EPS-PRIMARY>                                    40.16<F2>
<EPS-DILUTED>                                    40.16<F2>
<FN>
<F1>REGISTRANT HAS AN UNCLASSIFIED BALANCE SHEET.
<F2>EPS IS NET INCOME PER $1,000 LIMITED PARTNERSHIP UNIT.
</FN>
        

</TABLE>
Michigan Supreme Court Lansing, Michigan

Robert P. Young, Jr.,
Chief Justice

Michael F. Cavanag h Marilyn Kell y Stephen J. Markma n Diane M. Hathawa y Mary Beth Kell y Brian K. Zahra,
J ustices

I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

_______________________________________ __ Clerk September 21, 2011

h0914 

# Order

September 21, 2011

142754 & (70) (74)

BONNIE YACKISH, Plaintiff-Appellant/Cross-Appellee,

v SC: 142754 COA: 289671 STATE FARM MUTUAL AUTOMOBI LE Ingham CC: 06-000941-NF INSURANCE COMPANY, Defendant-Appellee/Cross-Appellant

________________ _______________ __________/

On order of the Court, the motion for l eave to file a brief amicus curiae is GRANTED. The application for leave to appe al the February 1, 2011 judgment of the Court of Appeals and the ap plication for leave to appeal as cross-appellant are considered, and they are DENIED, because we are not persuaded that the questions presented should be revi ewed by this Court.

C AVANAGH



### , M ARILYN 

### K ELLY



### , and H ATHAWAY



### , JJ., would grant plaintiff’s application for leave to appeal.
## Period Life Tables

- Office of the Chief Actuary
- Actuarial Publications

 Annual Trustees Reports provide estimates describing the actuarial status of Social Security's Old-Age and Survivors Insurance (OASI) and Disability Insurance (DI) Trust Funds under current law. In making these estimates, the Trustees make key demographic assumptions and economic assumptions. The intermediate set of assumptions reflects the Trustees’ best estimates of future experience. 

Actuarial Study Number 120here

Files are available from the following Trustees Reports

Footer menu
----

**Exhibit      32.1**

**SECTION      1350 CERTIFICATION**

|   | 1. | The                Report fully complies with the requirements of Section 13(a) or 15(d)                of                the Securities Exchange Act of 1934;                and |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2. | The                information contained in the Report fairly presents, in all material                respects, the financial condition and results of operations of the                Company. |
|--------|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | /s/                H. N. Padget, Jr.   H.                N. Padget, Jr., President and CEO(principal                executive officer)/s/                William R. Blanton   William                R. Blanton, Vice Chairman, COO/CFO(principal                financial officer) |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|